Last reviewed · How we verify

mastalgia-oil — Competitive Intelligence Brief

mastalgia-oil (mastalgia-oil) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Area: Pain Management.

phase 3 Pain Management Small molecule Live · refreshed every 30 min

Target snapshot

mastalgia-oil (mastalgia-oil) — Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University. Mastalgia-oil is used to alleviate breast pain, though its exact mechanism of action is not fully understood.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
mastalgia-oil TARGET mastalgia-oil Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University phase 3

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape

No sponsor landscape data.

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). mastalgia-oil — Competitive Intelligence Brief. https://druglandscape.com/ci/mastalgia-oil. Accessed 2026-06-10.

Build your own brief

Pick any drug + add comparators:

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing